Discover 889 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 889
Prevail Global Study
for
Coronary Artery Disease
Location: Birmingham AL, Huntsville AL, Atlanta GA, Nashville TN,
Sponsor: Medtronic Vascular
Sex: All
Age: 18+
Code: NCT06535854
Recruiting
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
for
Breast Cancer, Metastatic Breast Cancer
Location: Birmingham AL, Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06855654
Recruiting
Stent vs. Angioplasty for Treatment of Thrombosed AV Grafts: Long-Term Outcomes
for
Hyperplasia, Stenosis
Location: Birmingham AL
Sponsor: National Kidney Foundation, United States
Sex: All
Age: 19+
Code: NCT00496639
Recruiting
Platform Clinical Study for Conquering Scleroderma
for
Interstitial Lung Disease Due to Systemic Disease, Scleroderma
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
for
Herpes Simplex
Location: Birmingham AL, Nashville TN, Jackson MS, Knoxville TN,
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 0
Code: NCT00006132
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Regulation of Inflammatory Genes in Psoriasis
for
Psoriasis, Inflammation
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 19 - 70+
Code: NCT03125655
Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Birmingham AL, Atlanta GA, Pensacola FL, Jackson MS,
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Birmingham AL, Pensacola FL, Decatur IL, Kansas City MO,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07091019
Recruiting
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
for
Invasive Mould Infection
Location: Birmingham AL, Augusta GA, St Louis MO, Houston TX,
Sponsor: Elion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07215273
Phase2, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
for
Chronic Obstructive Pulmonary Disease
Location: Birmingham AL, Cordele GA, Charlotte NC,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07053423
Recruiting
Study of NTB-928 in R/R OC
for
Relapsed/Refractory Ovarian Carcinoma
Location: Birmingham AL, Fort Worth TX, Omaha NE, Lake Success NY
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Homewood AL, New Orleans LA, St Louis MO, Cincinnati OH,